201 related articles for article (PubMed ID: 8283030)
21. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.
Cao T; Lazdina U; Desombere I; Vanlandschoot P; Milich DR; Sällberg M; Leroux-Roels G
J Virol; 2001 Jul; 75(14):6359-66. PubMed ID: 11413302
[TBL] [Abstract][Full Text] [Related]
22. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
23. The hepatitis B virus e antigen cannot pass the murine placenta efficiently and does not induce CTL immune tolerance in H-2b mice in utero.
Reifenberg K; Deutschle T; Wild J; Hanano R; Gastrock-Balitsch I; Schirmbeck R; Schlicht HJ
Virology; 1998 Mar; 243(1):45-53. PubMed ID: 9527914
[TBL] [Abstract][Full Text] [Related]
24. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells.
Lazdina U; Cao T; Steinbergs J; Alheim M; Pumpens P; Peterson DL; Milich DR; Leroux-Roels G; Sällberg M
J Virol; 2001 Jul; 75(14):6367-74. PubMed ID: 11413303
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
26. Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines.
Ferrari C; Mondelli MU; Penna A; Fiaccadori F; Chisari FV
J Immunol; 1987 Jul; 139(2):539-44. PubMed ID: 2439590
[TBL] [Abstract][Full Text] [Related]
27. Role of T-cell tolerance in the persistence of hepatitis B virus infection.
Milich DR; Jones J; Hughes J; Maruyama T
J Immunother Emphasis Tumor Immunol; 1993 Oct; 14(3):226-33. PubMed ID: 8297904
[TBL] [Abstract][Full Text] [Related]
28. The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice.
Chen X; Lai J; Pan Q; Tang Z; Yu Y; Zang G
Vaccine; 2010 May; 28(23):3913-9. PubMed ID: 20394723
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B core antigen-specific IFN-gamma production of peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection.
Inoue M; Kakumu S; Yoshioka K; Tsutsumi Y; Wakita T; Arao M
J Immunol; 1989 Jun; 142(11):4006-11. PubMed ID: 2469730
[TBL] [Abstract][Full Text] [Related]
30. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.
Milich DR; Schödel F; Hughes JL; Jones JE; Peterson DL
J Virol; 1997 Mar; 71(3):2192-201. PubMed ID: 9032353
[TBL] [Abstract][Full Text] [Related]
31. Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. II. Synthetic Pre-S(2) immunogen.
Milich DR; Jones JE; McLachlan A; Bitter G; Moriarty A; Hughes JL
J Immunol; 1990 May; 144(9):3544-51. PubMed ID: 1691763
[TBL] [Abstract][Full Text] [Related]
32. Identification of a major hepatitis B core antigen (HBcAg) determinant by using synthetic peptides and monoclonal antibodies.
Colucci G; Beazer Y; Cantaluppi C; Tackney C
J Immunol; 1988 Dec; 141(12):4376-80. PubMed ID: 2461991
[TBL] [Abstract][Full Text] [Related]
33. A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen.
Chen MT; Billaud JN; Sällberg M; Guidotti LG; Chisari FV; Jones J; Hughes J; Milich DR
Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14913-8. PubMed ID: 15469922
[TBL] [Abstract][Full Text] [Related]
34. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?
Milich DR; Jones JE; Hughes JL; Price J; Raney AK; McLachlan A
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6599-603. PubMed ID: 2395863
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B core antigen is a potent inductor of interleukin-18 in peripheral blood mononuclear cells of healthy controls and patients with hepatitis B infection.
Manigold T; Böcker U; Chen J; Gundt J; Traber P; Singer MV; Rossol S
J Med Virol; 2003 Sep; 71(1):31-40. PubMed ID: 12858406
[TBL] [Abstract][Full Text] [Related]
37. Functional identification of agretopic and epitopic residues within an HBcAg T cell determinant.
Milich DR; Hughes JL; Houghten R; McLachlan A; Jones JE
J Immunol; 1989 Nov; 143(10):3141-7. PubMed ID: 2478618
[TBL] [Abstract][Full Text] [Related]
38. Immune response to hepatitis B virus proteins: relevance of the murine model.
Milich DR
Semin Liver Dis; 1991 May; 11(2):93-112. PubMed ID: 1832237
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
Chong CS; Cao M; Wong WW; Fischer KP; Addison WR; Kwon GS; Tyrrell DL; Samuel J
J Control Release; 2005 Jan; 102(1):85-99. PubMed ID: 15653136
[TBL] [Abstract][Full Text] [Related]
40. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
